Switch to:
GuruFocus has detected 2 Warning Signs with Valeant Pharmaceuticals International Inc $VRX.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Valeant Pharmaceuticals International Inc (NYSE:VRX)
Cash Flow from Others
$1,685 Mil (TTM As of Mar. 2017)

Valeant Pharmaceuticals International Inc's cash flow from others for the three months ended in Mar. 2017 was $-15 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Mar. 2017 was $1,685 Mil.


Definition

Valeant Pharmaceuticals International Inc Cash Flow from Others for the trailing twelve months (TTM) ended in Mar. 2017 was -48.9 (Jun. 2016 ) + 1103.5 (Sep. 2016 ) + 645.4 (Dec. 2016 ) + -15 (Mar. 2017 ) = $1,685 Mil.


Related Terms

Cash Flow from Operations


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Valeant Pharmaceuticals International Inc Annual Data

Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15Dec16
Cash Flow from Others 93-60561961342937392937661,810

Valeant Pharmaceuticals International Inc Quarterly Data

Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16Dec16Mar17
Cash Flow from Others 289121149199275110-491,104645-15
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

FEEDBACK